Activist investor Engine Capital LP urges the company to consider a sale or a spinoff of its noncore assets to become a more focused fuel and convenience retailer.
The FDA previously issued marketing denial orders for the Vuse Replacement Cartridge Menthol 4.8 percent G1 and the Vuse Replacement Cartridge Menthol 4.8 percent G2.